Expression of receptors for human angiogenin in vascular smooth muscle cells

European Journal of Biochemistry

Volumn 260, Issue 3, 1999, Pages 825-832

  Hatzi, Elissavet ^a   Badet, Josette ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b INSERM   (France)

Author keywords

Angiogenesis; Angiogenin; Placental ribonuclease inhibitor; Receptors; Smooth muscle cells

Indexed keywords

ANGIOGENIN; CELL RECEPTOR;

AFFINITY LABELING; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATTLE; CELL DENSITY; CELL PROLIFERATION; DISSOCIATION CONSTANT; DNA REPLICATION; DNA SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; BINDING, COMPETITIVE; CATTLE; CELL DIVISION; CELLS, CULTURED; HUMANS; IODINE RADIOISOTOPES; MUSCLE, SMOOTH, VASCULAR; PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; RIBONUCLEASE, PANCREATIC;

EID: 0033559215     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00222.x     Document Type: Article

References (44)

1. Fett, J.W., Strydom, D.J., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F. & Vallee, B.L. (1985) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-5486.
2. Strydom, D.J., Fett, J.W., Lobb, R.R., Alderman, E.M., Bethune, J.L., Riordan, J.F. & Vallee, B.L. (1985) Amino acid sequence of human tumor derived angiogenin. Biochemistry 24, 5486-5494.
3. Shapiro, R., Riordan, J.F. & Vallee, B.L. (1986) Characteristic ribo- nucleolytic activity of human angiogenin, Biochemistry 25, 3527-3532.
4. Rybak, S.M. & Vallee, B.L. (1988) Base cleavage specificity of angiogenin with Saccharomyces cerevisiae and Escherichia coil 5S RNAs. Biochemistry 27, 2288-2294.
5. Lee, F.S. & Vallee, B.L. (1989) Characterization of ribonucleolytic activity of angiogenin towards tRNA. Biochem. Biophys. Res. Commun. 161, 121-126.
6. Hallahan, T.W., Shapiro, R. & Vallee, B.L. (1991) Dual site model for the organogenic activity of angiogenin. Proc. Natl Acad. Sci. USA 88, 2222-2226.
7. Badet, J., Soncin, F., Guitton, J.-D., Lamare, O., Cartwright, T. & Barritault, D. (1989) Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc. Natl Acad. Sci. USA 86, 8427-8433.
8. Chamoux, M., Dehouck, M.P., Fruchart, J.C., Spik, G., Montreuil, J. & Cecchelli, R. (1991) Characterization of angiogenin receptors on bovine brain capillary endothelial cells. Biochem. Biophys. Res. Commun. 176, 833-839.
9. Hu, G.-F., Riordan, J.F. & Vallee, B.L. (1997) A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc. Natl Acad. Sci. USA 94, 2204-2209.
10. Shapiro, R., Strydom, D.J., Olson, K.A. & Vallee, B.L. (1987) Isolation of angiogenin from normal human plasma. Biochemistry 26, 5141-5146.
11. Moenner, M., Gusse, M., Hatzi, E. & Badet, J. (1994) The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis. Eur. J. Biochem. 226, 483-490.
12. Orlidge, A. & D'Amore, P.A. (1987) Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell. Biol. 105, 1455-1462.
13. Dodge, A.B., Lu, X. & D'Amore, P.A. (1993) Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth. J. Cell. Biochem. 53, 21-31.
14. Moore, F. & Riordan, J.F. (1990) Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry 29, 228-233.
15. Xiao, Y., Bicknell, R. & Vallee, B.L. (1989) Angiogenin depresses aortic smooth muscle cell cAMP by a pertussis toxin sensitive mechanism. Biochem. Biophys. Res. Commun. 163, 902-907.
16. Denèfle, P., Kovarik, S., Guitton, J.-D., Cartwright, T. & Mayaux, J.F. (1987) Chemical synthesis of a gene coding for human angiogenin, its expression in Escherichia coli and conversion of the product into its active form. Gene 56, 61-70.
17. Kurachi, K., Rybak, S.M., Fett, J.W., Shapiro, R., Strydom, D.J., Olson, K.A., Riordan, J.F., Davie, E.W. & Vallee, B.L. (1988) Expression of human angiogenin in cultured baby hamster kidney cells. Biochemistry 27, 6557-6562.
18. Badet, J., Soncin, F., N'Guyen, T. & Barritault, D. (1990) In vivo and in vitro studies of angiogenin - a potent angiogenic factor. Blood Coag. Fibrin. 1, 721-724.
19. Moenner, M., Hatzi, E. & Badet, J. (1997) Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions, in vitro. Cell Dev. Biol. 33, 553-561.
20. Perez-Reyes, N., Halbert, C.L., Smith, P.P., Benditt, E.P. & McDougall, J.K. (1992) Immortalization of primary human smooth muscle cells. Proc. Natl Acad. Sci. USA 89, 1224-1228.
21. Hunter, W.M. & Greenwood, F.C. (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (London) 194, 495-496.
22. 125I-epidermal growth factor in BALB 3T3 cells. J. Biol. Chem. 255, 1239-1241.
23. Munson, P.J. & Rodbard, D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
24. Bond, M.D. & Vallee, B.L. (1988) Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay. Biochemistry 27, 6282-6287.
25. Taylor, S. & Folkman, J. (1982) Protamine is an inhibitor of angiogenesis. Nature (London) 297, 307-312.
26. Folkman, J., Langer, R., Linhardt, R.J., Haudenschild, C. & Taylor, S. (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221, 719-725.
27. Au, Y.P.T., Kenagy, R.D., Clowes, M.M. & Clowes, A.W. (1993) Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23, 177-182.
28. Soncin, F., Strydom, D.J. & Shapiro, R. (1997) Interaction of heparin with human angiogenin. J. Biol. Chem. 272, 9818-9824.
29. Stein, C.A. (1993) Suramin: a novel antineoplastic agent with multiple potential mechanisms of action, Cancer Res. 53, 2239-2248.
30. Shapiro, R. & Vallee, B.L. (1987) Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl Acad. Sci. USA 84, 2238-2241.
31. Polakowski, I.J., Lewis, M.K., Muthukkaruppan, V.R., Erdman, B., Kubai, L. & Auerbach, R. (1993) A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice. Am. J. Pathol. 143, 507-517.
32. Lee, F.S., Shapiro, R. & Vallee, B.L. (1989) Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor, Biochemistry 28, 225-230.
33. Hu, G.-F., Strydom, D.J., Fett, J.W., Riordan, J.F. & Vallee, B.L. (1993) Actin is a binding protein for angiogenin. Proc. Natl Acad. Sci. USA 90, 1217-1221.
34. Olson, K.A., Fett, J.W., French, T.C., Key, M.E. & Vallee, B.L. (1995) Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl Acad. Sci. USA 92, 442-446.
35. Holley, R.W., Armour, R., Baldwin, J.H., Brown, K.D. & Yeh, Y.-C. (1977) Density-dependent regulation of growth of BSC-1 cells in cell culture: control of growth by serum factors. Proc. Natl Acad. Sci. USA 74, 5046-5050.
36. Neufeld, G. & Gospodarowicz, D. (1985) The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem. 260, 13860-13868.
37. Rizzino, A., Kazakoff, P., Ruff, E., Kuszynski, C. & Nebelsick, J. (1988) Regulatory effects of cell density on the binding of transforming growth factor β, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor. Cancer Res. 48, 4266-4271.
38. Thyberg, J. (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169, 183-265.
39. Thyberg, J. (1998) Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol. Histopathol. 13, 871-891.
40. Majack, R.A. (1987) Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J. Cell. Biol. 105, 465-471.
41. Owens, G.K., Geisteffer, A.A.T., Yang, Y.W.-H. & Komoriya, A. (1988) Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J. Cell Biol. 107, 771-780.
42. Ruoslahti, E. & Yamaguchi, Y. (1991) Proteoglycans as modulators of growth factor activities. Cell 64, 867-869.
43. Park, J.E., Keller, G.-A. & Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell. 4, 1317-1326.
44. Klagsbrun, M. & Dluz, S. (1993) Smooth muscle cell and endothelial cell growth factors. Trends Cardiovasc. Med. 3, 213-217.